Q4 2019 Holdings
Filed 2020-02-13 | 18 holdings | $160.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $160.0M | 1,547,994 | 99.8% |
| Constellation Pharmaceuticals(CNST) | COM | 210373106 | $118.5K | 2,516,242 | 0.1% |
| Milestone Pharmaceuticals Inc(MIST) | COM | 59935V107 | $33.1K | 2,066,529 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $30.0K | 767,938 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $25.2K | 958,765 | 0.0% |
| 10X Genomics Inc.(TXG) | COM | 88025U109 | $22.9K | 300,000 | 0.0% |
| Forty Seven Inc(FTSVEUR) | COM | 34983P104 | $20.3K | 516,381 | 0.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $19.7K | 575,000 | 0.0% |
| Iveric Bio Inc(OPHTEUR) | COM | 46583P102 | $14.6K | 1,699,797 | 0.0% |
| Kalvista Pharmaceuticals(KALV) | COM | 483497103 | $11.0K | 619,905 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $10.9K | 946,234 | 0.0% |
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | $10.8K | 5,016,164 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $8.9K | 1,561,389 | 0.0% |
| Myovant Sciences Ltd | COM | G637AM102 | $7.1K | 455,255 | 0.0% |
| Nextcure Inc | COM | 65343E108 | $6.7K | 119,693 | 0.0% |
| Obseva SA | COM | H5861P103 | $3.1K | 810,264 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $571 | 80,929 | 0.0% |
| Bellerophon Therapeutics(BLPHEUR) | COM | 078771102 | $134 | 383,955 | 0.0% |